These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2387533

  • 1. Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.
    Petru E, Sevin BU, Averette HE, Koechli OR, Perras JP, Hilsenbeck S.
    Gynecol Oncol; 1990 Aug; 38(2):181-6. PubMed ID: 2387533
    [Abstract] [Full Text] [Related]

  • 2. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC, Sprance HE, Carcangiu ML, Chambers JT, Schwartz PE.
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [Abstract] [Full Text] [Related]

  • 3. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K, Bian M, Zhu D, Liu W, Siu S.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [Abstract] [Full Text] [Related]

  • 4. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
    Knauf S, Bast RC.
    Int J Biol Markers; 1988 Apr; 3(2):75-81. PubMed ID: 3243980
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of ovarian tumor antigen NB/70K: monoclonal antibody assays for distinguishing ovarian cancer from other gynecologic disease.
    Knauf S.
    Am J Obstet Gynecol; 1988 May; 158(5):1067-72. PubMed ID: 3369485
    [Abstract] [Full Text] [Related]

  • 6. Ovarian cancer and tumor markers: sialic acid, galactosyltransferase and CA-125.
    Goldhirsch A, Berger E, Müller O, Maibach R, Misteli S, Buser K, Roesler H, Brunner K.
    Oncology; 1988 May; 45(4):281-6. PubMed ID: 3133621
    [Abstract] [Full Text] [Related]

  • 7. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
    Vardi JR, Tadros GH, Foemmel R, Shebes M.
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
    [Abstract] [Full Text] [Related]

  • 8. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
    Bast RC, Knauf S, Epenetos A, Dhokia B, Daly L, Tanner M, Soper J, Creasman W, Gall S, Knapp RC.
    Cancer; 1991 Oct 15; 68(8):1758-63. PubMed ID: 1913520
    [Abstract] [Full Text] [Related]

  • 9. Selectivity for ovarian cancer of an improved serum radioimmunoassay for human ovarian tumor-associated antigen NB/70K.
    Knauf S, Taillon-Miller P, Helmkamp BF, Bonfiglio TA, Beecham JB.
    Gynecol Oncol; 1984 Mar 15; 17(3):349-55. PubMed ID: 6706232
    [Abstract] [Full Text] [Related]

  • 10. The role of tumour markers in ovarian cancer.
    Gargano G, Correale M, Abbate I, Falco G, De Frenza N, Lorusso V, De Lena M, De Leonardis A.
    Clin Exp Obstet Gynecol; 1990 Mar 15; 17(1):23-9. PubMed ID: 2194706
    [Abstract] [Full Text] [Related]

  • 11. Clinical correlations of ovarian cancer antigen NB/70K: a preliminary report.
    Dembo AJ, Chang PL, Urbach GI.
    Obstet Gynecol; 1985 May 15; 65(5):710-4. PubMed ID: 3856794
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.
    Knauf S, Kalwas J, Helmkamp BF, Harwell LW, Beecham J, Lord EM.
    Cancer Immunol Immunother; 1986 May 15; 21(3):217-25. PubMed ID: 2421899
    [Abstract] [Full Text] [Related]

  • 13. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.
    Patsner B, Mann WJ, Vissicchio M, Loesch M.
    Gynecol Oncol; 1988 May 15; 30(1):98-103. PubMed ID: 2452774
    [Abstract] [Full Text] [Related]

  • 14. [Tumor markers in the monitoring of ovarian cancer].
    Xu SX.
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov 15; 25(6):345-7, 383. PubMed ID: 2282861
    [Abstract] [Full Text] [Related]

  • 15. Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen.
    Knauf S, Urbach GI.
    Cancer Res; 1981 Apr 15; 41(4):1351-7. PubMed ID: 6163521
    [Abstract] [Full Text] [Related]

  • 16. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM, Visser JJ, van Kamp GJ, Mensdorff-Pouilly S, van Dijk W, Hilgers J, Kenemans P.
    Tumour Biol; 1992 Apr 15; 13(3):121-32. PubMed ID: 1626178
    [Abstract] [Full Text] [Related]

  • 17. An improved radioimmunoassay for human ovarian tumor antigen NB/70K.
    Knauf S, Taillon-Miller P.
    Gynecol Oncol; 1984 Sep 15; 19(1):67-73. PubMed ID: 6469090
    [Abstract] [Full Text] [Related]

  • 18. The role of lipid-associated sialic acid (LSA) and prostate specific antigen (PSA) in the follow-up of prostatic cancer.
    Meyer U, Dierig C, Katopodis N, De Bruijn CH.
    Anticancer Res; 1993 Sep 15; 13(5C):1889-94. PubMed ID: 7505544
    [Abstract] [Full Text] [Related]

  • 19. The role of tumor markers in the preoperative diagnosis of ovarian cysts.
    Schwartz PE.
    Clin Obstet Gynecol; 1993 Jun 15; 36(2):384-94. PubMed ID: 7685676
    [No Abstract] [Full Text] [Related]

  • 20. Circulating tumor markers in the monitoring of gynecologic malignancies.
    Schwartz PE, Chambers SK, Chambers JT, Gutmann J, Katopodis N, Foemmel R.
    Cancer; 1987 Aug 01; 60(3):353-61. PubMed ID: 3594371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.